These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 4452124)
1. [Diagnostic and therapeutic difficulties in cerebral atherosclerosis (author's transl)]. Zdichynec B Cesk Psychiatr; 1974 Feb; 70(1):42-6. PubMed ID: 4452124 [No Abstract] [Full Text] [Related]
2. [Effect of papaverine on systemic and cerebral hemodynamics in atherosclerosis complicated by chronic cerebral circulatory insufficiency]. Komorovskaia IaM; Nechaĭ EE Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1308-12. PubMed ID: 6506974 [TBL] [Abstract][Full Text] [Related]
4. [Results of Paveron 75 therapy in negatively selected patients with cerebral function disorders]. Klaus P; Wiethaup H Med Welt; 1973 Sep; 24(37):1413-4. PubMed ID: 4587961 [No Abstract] [Full Text] [Related]
5. [Clinical manifestations and treatment of early cerebral atherosclerosis]. Mints AIa Klin Med (Mosk); 1981 Sep; 59(9):25-8. PubMed ID: 7311425 [No Abstract] [Full Text] [Related]
6. [Principles in the use of drugs in neurogeriatrics]. Mankovsky NB; Mintse AY; Vainchtock AB G Gerontol; 1972 Mar; 20(3):246-55. PubMed ID: 5030361 [No Abstract] [Full Text] [Related]
7. [On the symptomatology and therapy of cerebral arteriosclerosis in general practice]. Michaelis U Ther Ggw; 1966 Dec; 105(12):1593-600. PubMed ID: 4962890 [No Abstract] [Full Text] [Related]
8. Study of the effect of N-methyl carbamate on the electroencephalogram in cerebral arteriosclerosis. Mori A; Ishikawa Y; Mukoyama K Jpn Heart J; 1967 May; 8(3):234-41. PubMed ID: 5299490 [No Abstract] [Full Text] [Related]
9. [Experiences with a new drug combination in geriatric treatment]. Haydn G Med Welt; 1967 Oct; 43():2595-9. PubMed ID: 4388304 [No Abstract] [Full Text] [Related]
10. [Reaction time during ageing and in cerebral arteriosclerosis (author's transl)]. Kolozsi B; Molnár K; Bartók J Aktuelle Gerontol; 1981 Jan; 11(1):19-22. PubMed ID: 6112890 [TBL] [Abstract][Full Text] [Related]
11. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)]. Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Touboul D; Touboul PJ Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408 [No Abstract] [Full Text] [Related]
12. [The use of high doses of papaverine in cerebral arteriosclerotic vascular disease]. Bianchi G Clin Ter; 1970 Mar; 52(5):461-70. PubMed ID: 5421987 [No Abstract] [Full Text] [Related]
13. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes]. Probst G; Keiser G Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566 [No Abstract] [Full Text] [Related]
15. [Use of theophyllinyl 7- -n propane sulfonate of papaverine in rehabilitation and functional readaptation]. Blanc A; Perset P Therapeutique; 1971 Apr; 47(4):391-3. PubMed ID: 5564052 [No Abstract] [Full Text] [Related]
16. [Clinical studies of the vasodilating activity of a new drug with adrenosympatholytic action]. Melli A; Golinelli G Minerva Cardioangiol; 1967 Jun; 15(6):429-32. PubMed ID: 6056089 [No Abstract] [Full Text] [Related]
17. [Rheographic study of the activity of some vasoactive drugs on peripheral arterial circulation]. Capitanucci P; Martinelli M; De Gregorio M Minerva Cardioangiol; 1968 Nov; 16(11):1074-82. PubMed ID: 5707452 [No Abstract] [Full Text] [Related]